MYOZ2 Polyclonal Antibody

The protein encoded by MYOZ2 (myozenin 2) belongs to a family of sarcomeric proteins that bind to calcineurin, a phosphatase involved in calcium-dependent signal transduction in diverse cell types. These family members tether calcineurin to alpha-actinin at the z-line of the sarcomere of cardiac and skeletal muscle cells, and thus they are important for calcineurin signaling. Mutations in MYOZ2 cause cardiomyopathy familial hypertrophic type 16, a hereditary heart disorder.

The MYOZ2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of MYOZ2 protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and specificity towards MYOZ2.

MYOZ2, also known as myozenin 2, is a key regulator of cardiac muscle contraction and sarcomere organization. It plays a crucial role in maintaining the structural integrity of the sarcomere and contributes to the proper functioning of the heart. Dysregulation of MYOZ2 has been implicated in various cardiovascular diseases, making it an important target for research and diagnostic purposes.

The MYOZ2 Polyclonal Antibody exhibits exceptional performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It has been extensively validated for its specificity and sensitivity, ensuring reliable and accurate results.

With its superior quality and performance, the MYOZ2 Polyclonal Antibody is an indispensable tool for researchers and clinicians involved in cardiovascular research, diagnostics, and drug development. Its application in studying MYOZ2 function and its potential as a therapeutic target make it an invaluable asset in advancing our understanding of cardiovascular diseases.